Santhera Pharmaceuticals Holding's total assets for Q4 2024 were CHF152.49M, an increase of 40.87% from the previous quarter. CH:SANN total liabilities were CHF124.79M for the fiscal quarter, a 107.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.